We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
27 Jul 2020 - 30 Jul 2020

Pathology

Image: The Idylla system is a fully-automated, real-time polymerase chain reaction (PCR) based molecular testing system designed to offer results in a minimal amount of time (Photo courtesy of Biocartis).

Rapid Genomic Profiling of Colon Cancers Improves Therapy Selection

Colorectal cancer is a malignant tumor arising from the inner wall of the large intestine (colon) or rectum. Colorectal cancer is the third leading cause of cancer in both men and women in the USA. Most colorectal cancers develop from polyps. Removal of colon polyps can aid in the prevention of colorectal cancer. More...
09 Jul 2020
Image: The Bioanalyzer RNA 6000 Nano assay provides reliable and reproducible characterization of total RNA and mRNA from multiple sample types (Photo courtesy of Agilent Technologies).

RNA Sequencing as Alternative to Immunohistochemistry in Cancer Diagnostics

The conventionally used method for cancer diagnostics relies on immunohistochemical dyeing of tumor tissue sections. It allows detecting the presence and measuring the concentration of marker proteins characterizing malignant growths. The resulting microscope images indicate whether the tumor is malignant and what its molecular type is. This information is crucial for selecting the right therapy. More...
06 Jul 2020
Image: Aggregates of immune cells known as tertiary lymphoid structures (TLSs), seen here within a tumor of the soft tissues known as a rhabdomyosarcoma, are major players in the immune system’s fight against cancer (Photo courtesy of Johns Hopkins Kimmel Cancer Center).

Immune Cells Hampered Fighting Soft Tissue and Bone Sarcomas

Immunotherapies such as checkpoint inhibitors that enhance the body's natural ability to fight cancer have been only minimally successful in treating sarcomas which are rare cancers that grow in the soft tissues and bones. More...
06 Jul 2020
Image: The NF-light (Neurofilament light) ELISA kit allows fast quantification in less than three hours of neurofilament light in cerebrospinal fluid (Photo courtesy of Andreas Nilsson).

Blood Test Could Predict Multiple Sclerosis Progression

Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease of the central nervous system (CNS), with a highly variable inter-individual disease course. As a result, even if using existing clinical prognostic factors, the forecasting of long-term prognosis is often unreliable and imprecise. More...
01 Jul 2020
Image: Variability in prostate cancer–specific multigene panels; genetic testing registry as of August 2019 (Photo courtesy of Saud H. AlDubayan, MD).

Precision Medicine-Based Genetic Testing Developed for Prostate Cancer

Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in GT indications and management, and alternate genetic evaluation models that address the rising demand for genetic services. More...
01 Jul 2020
Image: uPath PD-L1 (SP263) image analysis (Photo courtesy of Roche)

Roche Advances Personalized Healthcare with Development of Image Analysis Algorithms Using Artificial Intelligence

Roche (Basel, Switzerland) has announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). More...
29 Jun 2020
Image: The QIAsymphony SP machine enables sample preparation of DNA, RNA, and bacterial and viral nucleic acids from a wide range of starting materials (Photo courtesy of Qiagen).

Blood Test Predicts Prostate Cancer Treatment Response

Prostate cancer became a bigger killer than breast cancer for the first time, official statistics revealed last year. More than 11,800 men a year - or one every 45 minutes - are now killed by the disease in the UK, compared with about 11,400 women dying of breast cancer. More...
17 Jun 2020


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2020 Globetech Media. All rights reserved.